Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1986 Feb;83(4):1092-6.
doi: 10.1073/pnas.83.4.1092.

Human small-cell lung cancers show amplification and expression of the N-myc gene

Comparative Study

Human small-cell lung cancers show amplification and expression of the N-myc gene

M M Nau et al. Proc Natl Acad Sci U S A. 1986 Feb.

Abstract

We have found that 6 of 31 independently derived human small-cell lung cancer (SCLC) cell lines have 5- to 170-fold amplified N-myc gene sequences. The amplification is seen with probes from two separate exons of N-myc, which are homologous to either the second or the third exon of the c-myc gene. Amplified N-myc sequences were found in a tumor cell line started prior to chemotherapy, in SCLC tumor samples harvested directly from tumor metastases at autopsy, and from a resected primary lung cancer. Several N-myc-amplified tumor cell lines also exhibited N-myc hybridizing fragments not in the germ-line position. In one patient's tumor, an additional amplified N-myc DNA fragment was observed and this fragment was heterogenously distributed in liver metastases. In contrast to SCLC with neuroendocrine properties, no non-small-cell lung cancer lines examined were found to have N-myc amplification. Fragments encoding two N-myc exons also detect increased amounts of a 3.1-kilobase N-myc mRNA in N-myc-amplified SCLC lines and in one cell line that does not show N-myc gene amplification. Both DNA and RNA hybridization experiments show that in any one SCLC cell line, only one myc-related gene is amplified and expressed. We conclude that N-myc amplification is both common and potentially significant in the tumorigenesis or tumor progression of SCLC.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Science. 1984 Jun 8;224(4653):1121-4 - PubMed
    1. Cancer Res. 1984 May;44(5):1735-42 - PubMed
    1. Cell. 1984 Jul;37(3):705-13 - PubMed
    1. Proc Natl Acad Sci U S A. 1984 Aug;81(15):4940-4 - PubMed
    1. Science. 1984 Dec 14;226(4680):1335-7 - PubMed

Publication types